Open an account

Splash Beverage Group

EDVA · NYSE American

$0.145+$0.01 (+7.41%)TodayMarket closed ·
Prev close $0.135

Latest news

  • News

    Endovia Health Sciences And Lupvindol BioSciences Receives FDA Determination That Proposed Use Of Cannepi For Control Of Pain Associated With Bone Cancer In Dogs Qualifies As 'Minor Use'

  • Press releaseGlobe Newswire

    Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway

  • NewsMohd Haider

    Endovia Health Sciences (EVDA) Stock Soars 48% After-Hours: Here's What's Going On

  • Press releaseGlobe Newswire

    Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways

  • News

    Endovia Health Sciences Announces U.S. Drug Enforcement Administration’s Decision To Transfer Marijuana From Schedule I To Schedule II Of Controlled Substances Act; Co. Plans To File Pre-Submission Conference With FDA For CannEpil

  • Press releaseGlobe Newswire

    Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline

  • Press releaseGlobe Newswire

    Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.